city New Delhi India city Hyderabad hospital covid-19 patient city New Delhi India city Hyderabad

Hetero’s drug to treat covid gets DCGI nod

Reading now: 710
www.livemint.com

NEW DELHI : Drugmaker Hetero on Monday said its generic version of Roche Holding AG’s tocilizumab, an immunosuppressant used to treat severe cases of covid-19, has been given emergency-use approval in India.

Hyderabad-based Hetero’s version of the drug will be available from September-end. “This approval is crucial for supply security in India, considering a global shortage of tocilizumab.

We will be working closely with the government to ensure equitable distribution," said Dr. B. Partha Saradhi Reddy, chairman, Hetero Group.

The drug was in short supply as infections and hospitalizations surged during the pandemic’s second wave, with patients having to pay multiples of the drug’s price to procure it.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA